The Centers for Medicare & Medicaid Services (CMS) recently published its Proposed 2026 Physician Fee Schedule Rule (Proposed Rule), with extensive implications for drug pricing, Average Sales Price (ASP) calculations, and...more
8/14/2025
/ Centers for Medicare & Medicaid Services (CMS) ,
Compliance ,
Drug Pricing ,
Fair Market Value ,
False Claims Act (FCA) ,
Manufacturers ,
Medicaid ,
Medicare ,
Pharmaceutical Industry ,
Proposed Rules ,
Regulatory Requirements ,
Reporting Requirements
In early 2022, Dutch regulators deployed a new methodology for calculating the maximum hourly rates that life sciences companies may pay to healthcare professionals (“HCPs”) and others engaged in fee-for-service consulting...more